Rising Demand for Home Healthcare Fuels Expansion of Pulse Oximeter Market
According to a recent publication by Meticulous Research®, the Pulse Oximeter Market is projected to grow significantly, reaching $3.40 billion by 2031 at a compound annual growth rate (CAGR) of 5.4% between 2024 and 2031. The primary drivers of this growth include the rising number of hospitalizations, the increasing use of pulse oximeters in newborn screening, the growing incidence of Chronic Obstructive Pulmonary Disease (COPD) and asthma, and the expanding penetration of over-the-counter (OTC) pulse oximeters. However, the market faces some restraints, particularly concerns about the accuracy and reliability of data from these devices, as well as regulatory issues surrounding OTC pulse oximeters.
Download Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5867
Market Segmentation
The pulse oximeter market is divided into several segments based on component, portability, technology, age group, end user, and geography. These segments allow for a comprehensive analysis of the market at both regional and global levels.
Component Segment: Devices Lead the Way
In 2024, the devices segment is expected to account for the largest share of the market. This can be attributed to the growing elderly population, the rising prevalence of chronic diseases, and the increasing use of pulse oximeters by athletes and fitness enthusiasts to monitor their oxygen saturation levels during workouts. Moreover, the integration of pulse oximetry technology into wearable devices has made it easier for users to monitor oxygen levels continuously, contributing to the segment's dominance. The data collected from wearable devices is also integrated with pulse oximeters to assess respiratory function and detect potential health issues like sleep apnea and respiratory infections.
Portability Segment: Fingertip Devices on the Rise
When it comes to portability, the fingertip pulse oximeter segment is anticipated to register the highest growth during the forecast period. Fingertip pulse oximeters are small, lightweight, and easy to use, making them highly popular among consumers. These devices offer precise readings with minimal power consumption, making them ideal for home use. Their ability to detect low oxygen saturation levels early makes them particularly valuable for individuals at risk of respiratory complications, further driving the segment’s growth.
Buy Now : https://www.meticulousresearch.com/Checkout/37714278
Technology Segment: Conventional Pulse Oximeters Take the Lead
In terms of technology, conventional pulse oximeters are projected to maintain the largest market share in 2024. Their affordability and widespread use in primary healthcare and emergency settings make them a staple in the market. Compared to connected devices, conventional pulse oximeters are more cost-effective, which makes them accessible to a broad range of healthcare facilities, including clinics and resource-limited settings. Their user-friendliness also contributes to their continued dominance.
Age Group Segment: Pediatrics to Experience Fastest Growth
The pediatrics segment is forecasted to experience the highest growth rate during the forecast period. The growing awareness of the importance of newborn screening for congenital and metabolic disorders is driving demand in this segment. Additionally, the rising number of newborn disease cases has prompted companies to develop more advanced screening devices for neonates. Recent product approvals, such as the FDA's clearance of Owlet Baby Care’s BabySat device, demonstrate the increasing focus on pediatric applications of pulse oximetry technology.
Cutomize My Report : https://www.meticulousresearch.com/request-customization/cp_id=5867
The competitive landscape of the pulse oximeter market is shaped by key players, including Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies, Inc. (U.S.), Masimo Corporation (U.S.), Beurer GmbH (Germany), Nonin Medical, Inc. (U.S.), Nihon Kohden Corporation (Japan), Drägerwerk AG & Co. KGaA (Germany), ICU Medical, Inc. (U.S.), and Spacelabs Healthcare (a subsidiary of OSI Systems, Inc.) (U.S.).
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now